SG64993G - Slow-release pharmaceutical composition - Google Patents

Slow-release pharmaceutical composition

Info

Publication number
SG64993G
SG64993G SG64993A SG64993A SG64993G SG 64993 G SG64993 G SG 64993G SG 64993 A SG64993 A SG 64993A SG 64993 A SG64993 A SG 64993A SG 64993 G SG64993 G SG 64993G
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
slow
tryptophan
fumaric acid
release pharmaceutical
Prior art date
Application number
SG64993A
Other languages
English (en)
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of SG64993G publication Critical patent/SG64993G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
SG64993A 1985-09-26 1993-05-18 Slow-release pharmaceutical composition SG64993G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21327785 1985-09-26

Publications (1)

Publication Number Publication Date
SG64993G true SG64993G (en) 1993-08-06

Family

ID=16636441

Family Applications (1)

Application Number Title Priority Date Filing Date
SG64993A SG64993G (en) 1985-09-26 1993-05-18 Slow-release pharmaceutical composition

Country Status (15)

Country Link
US (1) US5188840A (fr)
EP (2) EP0218148B1 (fr)
JP (1) JPH0772142B2 (fr)
KR (1) KR950010145B1 (fr)
AT (2) ATE62408T1 (fr)
AU (1) AU587281B2 (fr)
CA (1) CA1282327C (fr)
DE (2) DE3689983T2 (fr)
DK (2) DK166478B1 (fr)
ES (1) ES2001993A6 (fr)
FI (1) FI86146C (fr)
HK (1) HK65393A (fr)
IE (2) IE66255B1 (fr)
NO (1) NO175763C (fr)
SG (1) SG64993G (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437300A1 (de) * 1984-10-11 1986-04-17 Fritz 5882 Meinerzhagen Sträter Konzepthalter zur anwendung an schreib-, zeichen-, bildschirmarbeitsplaetzen u.dgl.
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
CA1323833C (fr) * 1987-04-28 1993-11-02 Yatindra M. Joshi Compositions pharmaceutiques sous forme de granules et methode de fabrication
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
IT1256022B (it) * 1992-06-08 1995-11-20 Preparazioni farmaceutiche stabili di nicorandil
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5602180A (en) * 1995-03-31 1997-02-11 World Health Group Method of administering EDTA complexes
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FR2742659B1 (fr) * 1995-12-22 1998-03-13 Pf Medicament Procede de fabrication de minispheres matricielles a liberation prolongee
WO1999017751A1 (fr) * 1997-10-03 1999-04-15 Smithkline Beecham Corporation Formes galeniques solides a liberation controlee au carbonate de lithium
EP1077065B1 (fr) * 1998-05-15 2004-08-04 Chugai Seiyaku Kabushiki Kaisha Preparations a liberation controlee
JP4659316B2 (ja) * 1999-08-09 2011-03-30 大日本住友製薬株式会社 キトサン粉末含有固形製剤およびその製造方法
HUP0104472A3 (en) 1999-09-30 2002-12-28 Penwest Pharmaceuticals Co Pat Sustained release matrix systems for highly soluble drugs
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
CA2439687A1 (fr) 2001-03-01 2002-09-12 Hollis-Eden Pharmaceuticals, Inc. Traitement de deficiences affectant les globules sanguins
US6720356B2 (en) * 2001-04-20 2004-04-13 Spencer Feldman Magnesium di-potassium EDTA complex and method of administration
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
ATE404179T1 (de) * 2001-09-28 2008-08-15 Mcneil Ppc Inc Darreichungsformen mit kern und äusserer hülle
US20060013875A1 (en) * 2002-05-29 2006-01-19 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040228918A1 (en) * 2003-01-02 2004-11-18 Chih-Ming Chen Granule modulating hydrogel system
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
WO2006110172A2 (fr) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals.Inc. Analogues de steroides, procedes de caracterisation et traitements
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
WO2013153210A1 (fr) 2012-04-13 2013-10-17 Nanoscape Ag Formulation à libération prolongée
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
ES2823000T3 (es) 2013-10-07 2021-05-05 Impax Laboratories Llc Formulaciones muco-adhesivas de liberación controlada de levodopa y/o ésteres de levodopa y usos de las mismas

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES300432A1 (es) * 1963-06-04 1964-11-16 Abbott Lab Procedimiento para producir una composición analgésica
US3577491A (en) * 1968-01-02 1971-05-04 Miles Lab Tableting
US3849558A (en) * 1969-06-03 1974-11-19 Sumitomo Chemical Co Pharmaceutical compositions having controlled gastro-intestinal absorption
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
BE759520A (fr) * 1969-11-28 1971-04-30 Aspro Nicholas Ltd Compositions d'aspirine
US3903255A (en) * 1971-05-17 1975-09-02 Rohm & Haas Effervescent potassium chloride tablet
JPS5115094B2 (fr) * 1972-11-01 1976-05-14
US3993999A (en) * 1975-05-16 1976-11-23 Texas Instruments Incorporated Amplitude modulation scanning antenna system
US4021546A (en) * 1976-03-08 1977-05-03 Interx Research Corporation Pro-drug forms of digoxin and method of preparing and using same
DE2656227C2 (de) * 1976-12-11 1985-07-04 Bayer Ag, 5090 Leverkusen Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4180559A (en) * 1978-01-05 1979-12-25 Richardson-Merrell Inc. Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum
US4342764A (en) * 1979-05-29 1982-08-03 Ciba-Geigy Corporation Guanidine compounds, pharmaceutical compositions and use
US4406896A (en) * 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
DE3011327A1 (de) * 1980-03-24 1981-10-01 Basf Ag, 6700 Ludwigshafen 1-aroyl-2-phenylamino-2-imidazoline, ihre herstellung und verwendung
ZA823333B (fr) * 1981-04-24 1983-11-14
IT1198386B (it) * 1982-07-06 1988-12-21 Lepetit Spa Un prodotto a rilascio protratto contenente il suloctidile
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU191542B (en) * 1983-04-08 1987-03-30 Boehringer Ingelheim Ltd Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
DE3315797A1 (de) * 1983-04-30 1984-10-31 Beiersdorf Ag, 2000 Hamburg Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US4530920A (en) * 1983-11-07 1985-07-23 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
FR2588559B1 (fr) * 1985-10-11 1988-03-11 Bp Chimie Sa Procede de polymerisation ou de copolymerisation d'alpha-olefines en presence d'un systeme catalytique ziegler-natta ameliore

Also Published As

Publication number Publication date
AU6273086A (en) 1987-04-02
DK455286A (da) 1987-03-27
FI863889A0 (fi) 1986-09-26
ATE108647T1 (de) 1994-08-15
EP0218148B1 (fr) 1991-04-10
DE3678661D1 (de) 1991-05-16
DE3689983T2 (de) 1995-02-23
DE3689983D1 (de) 1994-08-25
NO863796L (no) 1987-03-27
CA1282327C (fr) 1991-04-02
ES2001993A6 (es) 1988-07-01
HK65393A (en) 1993-07-16
IE862468L (en) 1987-03-26
FI863889A (fi) 1987-03-27
KR870002838A (ko) 1987-04-13
DK166478B1 (da) 1993-06-01
US5188840A (en) 1993-02-23
AU587281B2 (en) 1989-08-10
KR950010145B1 (ko) 1995-09-11
DK108192D0 (da) 1992-08-31
FI86146B (fi) 1992-04-15
FI86146C (fi) 1992-07-27
EP0386801A3 (en) 1990-11-07
DK108192A (da) 1992-08-31
NO175763B (no) 1994-08-29
NO175763C (no) 1994-12-07
NO863796D0 (no) 1986-09-24
JPH0772142B2 (ja) 1995-08-02
IE81099B1 (en) 2000-03-08
DK170110B1 (da) 1995-05-29
ATE62408T1 (de) 1991-04-15
EP0386801A2 (fr) 1990-09-12
IE940953L (en) 1987-03-26
EP0218148A1 (fr) 1987-04-15
DK455286D0 (da) 1986-09-24
IE66255B1 (en) 1995-12-27
EP0386801B1 (fr) 1994-07-20
JPS62149630A (ja) 1987-07-03

Similar Documents

Publication Publication Date Title
AU587281B2 (en) Slow-release pharmaceutical agent
FI881409A0 (fi) Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle
HUT51254A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
CA2380757A1 (fr) Agent pharmaceutique comprenant un derive benzamide comme principe actif
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
MY102368A (en) Solid sustained-release composition
WO2001010415B1 (fr) Liant pour compositions pharmaceutiques